# altcoin / # bitcoin / # blockchain / # exchange / # events / # ICO / # trends / # finance / # Russian news

Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact

2025-1-8 02:44 pm NEWS
At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss drug.
Read The Rest at
marketwatch.com
ozempic maker nordisk after trial disappointment expands potential billion
SOURCE:

You May Also Like

1 I gave birth to triplets when I was 41 and my husband was 49. There are benefits and drawbacks to being a parent of 3 at an older age.
I gave birth to triplets when I was 41 and my husband was 49. There are benefits and drawbacks to being a parent of 3 at an older age.
2 Cipher Mining rockets 34% after $5.5B data center deal with Amazon
Cipher Mining rockets 34% after $5.5B data center deal with Amazon
3 Inside Coinbase’s $2.5B BVNK deal – Could this be crypto’s ‘new Western Union’ moment?
Inside Coinbase’s $2.5B BVNK deal – Could this be crypto’s ‘new Western Union’ moment?
4 Justin Baldoni loses lawsuit against Blake Lively after missing deadline
Justin Baldoni loses lawsuit against Blake Lively after missing deadline
5 DeXe surges 12% amid $350K inflow – But THIS hurdle warns caution!
DeXe surges 12% amid $350K inflow – But THIS hurdle warns caution!



© 2022 CRYPTONEWS
Cryptocurrency news – Bitcoin, etherium, altcoins, Blockchain, crypto exchange, law regulation | donate